{"issuance_frequency":"","notes_translated":{"fr":"Tous les établissements pharmaceutiques canadiens doivent posséder une licence d’établissement de produits pharmaceutiques pour fabriquer, emballer, étiqueter, distribuer, importer ou vendre en gros un médicament ou en faire l’essai, conformément à la Partie C, Division 1A, du Règlement sur les aliments et drogues. ","en":"All Canadian drug establishments must have a drug establishment licence to fabricate, package/label, distribute, import, wholesale or test a drug as required under Part C, Division 1A of the Food and Drug Regulations."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"4e9f3e95-6909-4385-af4e-611b5a4e2803","metadata_created":"2020-08-28T13:01:21.919959","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-08-28T13:01:21.919965","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-08-28","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Pandémie de COVID-19","licences d’établissement de produits pharmaceutiques","Partie C","Division 1A du Règlement sur les aliments et drogues"],"en":["COVID-19 pandemic","Drug establishment licences","Part C","Division 1A of the Food and Drug Regulations."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Les licences d’établissement de produits pharmaceutiques et la COVID-19","en":"Drug establishment licences and COVID-19"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"4e9f3e95-6909-4385-af4e-611b5a4e2803","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"171ba65d-7cb9-4b52-afd2-b151bb94ba9c","related_relationship":"","name_translated":{"fr":"Les licences d’établissement de produits pharmaceutiques et la COVID-19","en":"Drug establishment licences and COVID-19"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Drug establishment licences and COVID-19","language":["en"],"created":"2020-08-28T13:01:22.064894","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/drug-establishment-licences.html","last_modified":null,"position":0,"revision_id":"6934de75-2e75-49c1-974c-de4f8304539d","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"4e9f3e95-6909-4385-af4e-611b5a4e2803","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cc5600ae-04f5-452f-bd1b-2b5f497dafdb","related_relationship":"","name_translated":{"fr":"Les licences d’établissement de produits pharmaceutiques et la COVID-19","en":"Drug establishment licences and COVID-19"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Drug establishment licences and COVID-19","language":["fr"],"created":"2020-08-28T13:01:22.064900","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/licences-etablissement/drogues-licences-etablissement.html","last_modified":null,"position":1,"revision_id":"6934de75-2e75-49c1-974c-de4f8304539d","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-08-08 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"4e9f3e95-6909-4385-af4e-611b5a4e2803","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"All Canadian drug establishments must have a drug establishment licence to fabricate, package/label, distribute, import, wholesale or test a drug as required under Part C, Division 1A of the Food and Drug Regulations.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Drug establishment licences and COVID-19","revision_id":"6934de75-2e75-49c1-974c-de4f8304539d"}